These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 14867569)
1. [Dangers of intravesical application of sulfonamides]. SCHON H; WILLE-BAUMKAUFF H Z Urol; 1951; 44(7):433-53. PubMed ID: 14867569 [No Abstract] [Full Text] [Related]
2. [On the treatment of acute and chronic cystitis with the chronically contracted bladder]. KILLIAN H Praxis; 1960 Dec; 49():1170-5. PubMed ID: 13755963 [No Abstract] [Full Text] [Related]
3. [Experimental contributions on sulfonamide instillation in the bladder with aristamid]. MAUERMAYER W Z Urol; 1951; 44(9):594-604. PubMed ID: 14932287 [No Abstract] [Full Text] [Related]
4. [Local sulfonamide therapy of bladder inflammations]. OEHLERT G Med Klin; 1954 Oct; 49(42):1693-5. PubMed ID: 13223356 [No Abstract] [Full Text] [Related]
5. [BACTERIURIA AND PYURIA IN CHRONIC URINARY TRACT INFECTIONS]. HOIGNE R; HODLER J; STRULLER T Praxis; 1964 Mar; 53():406-10. PubMed ID: 14205217 [No Abstract] [Full Text] [Related]
7. [Gantrisin in chemotherapy of cystitis]. BECHER H Med Monatsschr; 1951 Nov; 5(11):786-7. PubMed ID: 14910244 [No Abstract] [Full Text] [Related]
8. Treatment of cystitis and cystopyelitis in gynecological practice. SCHNEIDER-PAAS CE Med Klin; 1954 Oct; 49(40):1622-3. PubMed ID: 13223337 [No Abstract] [Full Text] [Related]
9. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide. Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032 [TBL] [Abstract][Full Text] [Related]
10. [Aristasept in gynecologic practice]. KEMPF H Ther Ggw; 1955 Feb; 94(2):64-5. PubMed ID: 14373650 [No Abstract] [Full Text] [Related]
11. Protease-activated receptor-2-mediated contraction of urinary bladder is enhanced in cyclophosphamide-treated rats. Nakahara T; Kubota Y; Saito M; Sakamoto K; Ishii K Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):212-9. PubMed ID: 14673513 [TBL] [Abstract][Full Text] [Related]
12. Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis. Charrua A; Cruz CD; Jansen D; Rozenberg B; Heesakkers J; Cruz F BJU Int; 2015 Mar; 115(3):452-60. PubMed ID: 25041193 [TBL] [Abstract][Full Text] [Related]
13. Effect of interstitial cystitis on drug absorption from urinary bladder. Gao X; Buffington CA; Au JL J Pharmacol Exp Ther; 1994 Nov; 271(2):818-23. PubMed ID: 7965801 [TBL] [Abstract][Full Text] [Related]
14. Computed tomography findings of human polyomavirus BK (BKV)-associated cystitis in allogeneic hematopoietic stem cell transplant recipients. Schulze M; Beck R; Igney A; Vogel M; Maksimovic O; Claussen CD; Faul C; Horger M Acta Radiol; 2008 Dec; 49(10):1187-94. PubMed ID: 18932047 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic intravesical instillation of epinephrine prevents cyclophosphamide-induced hemorrhagic cystitis in rats. Chow YC; Yang S; Huang CJ; Tzen CY; Su YH; Wang PS Exp Biol Med (Maywood); 2007 Apr; 232(4):565-70. PubMed ID: 17392493 [TBL] [Abstract][Full Text] [Related]
16. VESICOURETERAL REFLUX AND ITS SURGICAL CORRECTION. MATHISEN W Surg Gynecol Obstet; 1964 May; 118():965-71. PubMed ID: 14143463 [No Abstract] [Full Text] [Related]
17. Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis. Jhang JF; Jiang YH; Kuo HC Int J Urol; 2014 Apr; 21 Suppl 1():49-55. PubMed ID: 24807497 [TBL] [Abstract][Full Text] [Related]
18. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. Chuang YC; Lee WC; Lee WC; Chiang PH J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290 [TBL] [Abstract][Full Text] [Related]
19. [The use of dimethyl sulfoxide in the treatment of intractable urinary frequency]. Okamura K; Mizunaga M; Arima S; Tokunaka S; Inada F; Takamura T; Yachiku S Hinyokika Kiyo; 1985 Apr; 31(4):627-31. PubMed ID: 4036738 [TBL] [Abstract][Full Text] [Related]
20. Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats. Yıldız N; Alpay H; Tuğtepe H; Özdemir Kumral ZN; Akakın D; İlki A; Şener G; Ç Yeğen B Int J Urol; 2015 Jun; 22(6):598-603. PubMed ID: 25808602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]